Literature DB >> 11969334

Analysis and design of perfusion-based event-related fMRI experiments.

Thomas T Liu1, Eric C Wong, Lawrence R Frank, Richard B Buxton.   

Abstract

Perfusion-based functional magnetic resonance imaging (fMRI) using arterial spin labeling (ASL) methods has the potential to provide better localization of the functional signal to the sites of neural activity compared to blood oxygenation level-dependent (BOLD) contrast fMRI. At present, experiments using ASL have been limited to simple block and periodic single-trial designs. We present here an adaptation of the general linear model to perfusion-based fMRI that enables the design and analysis of more complicated designs, such as random and semirandom event-related designs. Formulas for the least-squares estimate of the perfusion response and the F statistic for the detection of a response are derived. Exact expressions and useful approximations for detection power and estimation efficiency are presented, and it is shown that the trade-off between power and efficiency for perfusion experiments is similar to that previously observed for BOLD experiments. The least-squares estimate is compared with an estimate formed from the running subtraction of tag and control images. The running subtraction estimate is shown to be approximately equal to a temporally low-pass-filtered version of the least-squares estimate. Numerical simulations and results from ASL experiments are used to support the theoretical findings. 2002 Elsevier Science (USA).

Mesh:

Substances:

Year:  2002        PMID: 11969334     DOI: 10.1006/nimg.2001.1038

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  14 in total

1.  Quantitative analysis of arterial spin labeling FMRI data using a general linear model.

Authors:  Luis Hernandez-Garcia; Hesamoddin Jahanian; Daniel B Rowe
Journal:  Magn Reson Imaging       Date:  2010-04-24       Impact factor: 2.546

2.  Estimation efficiency and statistical power in arterial spin labeling fMRI.

Authors:  Jeanette A Mumford; Luis Hernandez-Garcia; Gregory R Lee; Thomas E Nichols
Journal:  Neuroimage       Date:  2006-07-24       Impact factor: 6.556

3.  Real-time functional MRI using pseudo-continuous arterial spin labeling.

Authors:  Luis Hernandez-Garcia; Hesamoddin Jahanian; Mark K Greenwald; Jon-Kar Zubieta; Scott J Peltier
Journal:  Magn Reson Med       Date:  2011-03-28       Impact factor: 4.668

Review 4.  Characterizing Resting-State Brain Function Using Arterial Spin Labeling.

Authors:  J Jean Chen; Kay Jann; Danny J J Wang
Journal:  Brain Connect       Date:  2015-10-06

5.  Optimized simultaneous ASL and BOLD functional imaging of the whole brain.

Authors:  Vincent J Schmithorst; Luis Hernandez-Garcia; Jennifer Vannest; Akila Rajagopal; Greg Lee; Scott K Holland
Journal:  J Magn Reson Imaging       Date:  2013-09-24       Impact factor: 4.813

6.  Dual-echo ASL contributes to decrypting the link between functional connectivity and cerebral blow flow.

Authors:  Silvia F Storti; Ilaria Boscolo Galazzo; Stefania Montemezzi; Gloria Menegaz; Francesca B Pizzini
Journal:  Hum Brain Mapp       Date:  2017-09-08       Impact factor: 5.038

7.  Calibrated bold fMRI with an optimized ASL-BOLD dual-acquisition sequence.

Authors:  María A Fernández-Seara; Zachary B Rodgers; Erin K Englund; Felix W Wehrli
Journal:  Neuroimage       Date:  2016-08-05       Impact factor: 6.556

8.  Arterial impulse model for the BOLD response to brief neural activation.

Authors:  Jung Hwan Kim; David Ress
Journal:  Neuroimage       Date:  2015-09-10       Impact factor: 6.556

9.  Change point estimation in multi-subject fMRI studies.

Authors:  Lucy F Robinson; Tor D Wager; Martin A Lindquist
Journal:  Neuroimage       Date:  2009-09-04       Impact factor: 6.556

10.  Measurement of OEF and absolute CMRO2: MRI-based methods using interleaved and combined hypercapnia and hyperoxia.

Authors:  Richard G Wise; Ashley D Harris; Alan J Stone; Kevin Murphy
Journal:  Neuroimage       Date:  2013-06-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.